Marshall Wace North America’s X4 Pharmaceuticals XFOR Stock Holding History

Marshall Wace North America’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$139K	Buy	+875	New	+$144K	﹤0.01%	1348
2020 Q2	–	Sell	-63	Closed	-$19K	–	1528
2020 Q1	$19K	Buy	+63	New	+$17.9K	﹤0.01%	1139

Other funds holding XFOR

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Altium Capital Management New York $42M AUM

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return